Rosenblum Mark J
SEC insider (Form 3/4/5 filer). CIK 0001329154. Chief Financial Officer at Decoy Therapeutics Inc. (DCOY). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in HOUSTON, TX.
Companies Rosenblum Mark J has filed insider reports for
- Decoy Therapeutics Inc. (DCOY): Officer, Chief Financial Officer
Rosenblum Mark J
CIK: 0001329154
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DCOY
Decoy Therapeutics Inc.
Officer
